Streetbeat News

Earnings

ESEA

Zacks discusses the potential for value investors to consider Euroseas (ESEA) stock, focusing on the Zacks Rank system which emphasizes earnings estimates and revisions.

Portfolio Pulse from

January 02, 2025 | 4:30 pm

WBA

Analysts predict that Walgreens Boots Alliance (WBA) will report a decline in earnings in its upcoming report. The company lacks the necessary factors for an earnings beat.

Portfolio Pulse from

January 02, 2025 | 4:30 pm

DGX

Quest Diagnostics will release its Q4 and full year 2024 financial results on January 30, 2025, before the market opens.

Portfolio Pulse from

January 02, 2025 | 4:15 pm

VLNSF

Velan Inc. will release its financial results for the third quarter ended November 30, 2024, on January 14, 2025.

Portfolio Pulse from

January 02, 2025 | 4:15 pm

AMR

The article discusses whether investors are currently undervaluing Alpha Metallurgical Resources (AMR), highlighting the importance of the Zacks Rank system which focuses on earnings estimates and revisions to identify strong stocks.

Portfolio Pulse from

January 02, 2025 | 4:00 pm

CAH

The article discusses whether Cardinal Health (CAH) stock is currently undervalued, focusing on the Zacks Rank system which uses earnings estimates and revisions to identify strong stocks.

Portfolio Pulse from

January 02, 2025 | 4:00 pm

DVA

The article discusses whether DaVita (DVA) stock is a good buy for value investors, focusing on the Zacks Rank system which emphasizes earnings estimates and revisions.

Portfolio Pulse from

January 02, 2025 | 4:00 pm

WRB

The article discusses whether W.R. Berkley (WRB) stock is currently undervalued, focusing on the Zacks Rank system which uses earnings estimates and revisions to identify strong stocks. The analysis also considers value, growth, and momentum trends.

Portfolio Pulse from

January 02, 2025 | 4:00 pm

BBAR

The article discusses whether investors are undervaluing BBVA Banco Frances (BBAR) by focusing on the Zacks Rank system, which emphasizes earnings estimates and revisions. It highlights the importance of value, growth, and momentum trends in identifying strong stock picks.

Portfolio Pulse from

January 02, 2025 | 4:00 pm

BIOA

BioAge Labs, Inc. (BIOA) has experienced a significant decline of 67.99% over the past four weeks, leading to an oversold status. This, along with positive revisions in earnings estimates by analysts, suggests a potential trend reversal for the stock.

Portfolio Pulse from

January 02, 2025 | 4:00 pm